Viemed Healthcare (VMD) Q2 2026 earnings — TrendMatrix coverage
MISS-30.0% vs estimateEPS $0.07 vs $0.10 estVerdict Buy (Wait) → Hold
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
Key numbers
- Reported EPS
- $0.07
- Estimate
- $0.10
- Surprise
- -30.0%
- Revenue (period 2026-06-30)
- $78.1M
- Score at report (before → after)
- 5.8 → 5.7/10
Revenue source: xbrl.
Report record · Q2 2026
How the report landed
Viemed Healthcare (VMD) missed the $0.10 estimate with diluted EPS of $0.07 — a large 30.0% shortfall. TrendMatrix's engine moved from Buy (Wait) (5.8/10) to Hold at 5.7/10 after the report.